The global sleeping aids market size is being driven by the increasing geriatric population, rising prevalence of obstructive sleep apnea (OSA) and insomnia, and expanding healthcare sector. It generated a revenue of $69.5 billion in 2017 and is slated to grow at a CAGR of 6.5% during the forecast period. Sleeping aids are medical devices and drugs that assist a person in falling asleep. Products in the market range from sleep apnea devices and medication to mattresses and pillows, and sleep laboratory devices.
Download sample copy of this report at@ https://www.psmarketresearch.com/market-analysis/sleeping-aids-market/report-sample
In the sleeping aids market, continuous positive airway pressure (CPAP) devices are being increasingly used by sleep apnea patients. These offer uninterrupted sleep to patients by controlling snoring. This device consists of a mask that is attached to a tube, along with a pump. The demand for these devices is increasing due to technological improvements, such as a mask that covers only the nose and use of soft material. CPAP humidifiers, which keep the inside-air moist, are a type of CPAP devices manufactured by companies such as ResMed Inc., Respironics Inc., and Koninklijke Philips N.V.
Governments and various private organizations are now increasingly investing in research and development activities to find a better treatment for sleep disorders. Numerous start-ups working on finding an effective way of controlling and preventing such disorders are being supported by governments of developing and developed nations alike. This has enabled the customers to access tailor-made therapies, sleep monitoring devices, and mobile apps. For instance, Oventus Medical won a $2,950,000 Australian federal government grant in February 2017 for research on sleep apnea.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=sleeping-aids-market
The segments of the market are region, offering, and sleep disorder. Based on sleep disorder, the sleeping aids market categories are sleep walking, insomnia, narcolepsy, sleep apnea, restless leg syndrome, and others. The sleep apnea category is projected to exhibit the highest CAGR of 7.2% during the forecast period. This can be attributed to the changing lifestyle habits of people, rising geriatric population, and sleep apnea disorders.
Hence, the market for sleeping aids is expected to grow because of the above-mentioned factors during the forecast period.